(+)-pilocarpine increases expression ISO RGD:62205 6480464 Pilocarpine results in increased expression of SLC6A6 mRNA CTD PMID:21219332 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:69004 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of SLC6A6 mRNA CTD PMID:26821219 17alpha-ethynylestradiol affects expression ISO RGD:62205 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:69004 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:26865667 17alpha-ethynylestradiol decreases expression ISO RGD:69004 6480464 Ethinyl Estradiol results in decreased expression of SLC6A6 mRNA CTD PMID:18936297 17alpha-ethynylestradiol multiple interactions ISO RGD:62205 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC6A6 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:62205 6480464 Ethinyl Estradiol results in decreased expression of SLC6A6 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:69004 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC6A6 mRNA, Estradiol promotes the reaction [ESR2 protein affects the expression of SLC6A6 mRNA] CTD PMID:19619570 , PMID:20404318 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:69004 6480464 Estradiol results in increased expression of SLC6A6 mRNA CTD PMID:15223131 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:62205 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69004 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC6A6 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69004 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62205 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A6 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62205 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:15328365 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:21215274 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69004 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A6 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A6 mRNA CTD PMID:16984957 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62205 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A6 mRNA CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62205 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC6A6 mRNA more ... CTD PMID:16984957 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:62205 6480464 2 more ... CTD PMID:25768209 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC6A6 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:16984957 more ... 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:28300664 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SLC6A6 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC6A6 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane increases expression ISO RGD:62205 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SLC6A6 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:69004 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SLC6A6 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:62205 6480464 Fenretinide results in increased expression of SLC6A6 mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of SLC6A6 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SLC6A6 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC6A6 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC6A6 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:69004 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC6A6 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC6A6 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:69004 6480464 Aflatoxin B1 affects the expression of SLC6A6 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:69004 6480464 Aflatoxin B1 results in increased expression of SLC6A6 mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO RGD:69004 6480464 Aflatoxin B1 results in increased methylation of SLC6A6 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:62205 6480464 Aflatoxin B1 results in decreased expression of SLC6A6 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:69004 6480464 Tretinoin results in increased expression of SLC6A6 mRNA CTD PMID:23830798 , PMID:33167477 alpha-pinene multiple interactions ISO RGD:69004 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC6A6 mRNA CTD PMID:32699268 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of SLC6A6 mRNA CTD PMID:18355885 , PMID:19483382 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of SLC6A6 mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC6A6 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:69004 6480464 aristolochic acid I results in decreased expression of SLC6A6 mRNA CTD PMID:33212167 arsane affects expression ISO RGD:69004 6480464 Arsenic affects the expression of SLC6A6 mRNA CTD PMID:18414638 arsane affects methylation ISO RGD:69004 6480464 Arsenic affects the methylation of SLC6A6 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:69004 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 arsenic atom affects expression ISO RGD:69004 6480464 Arsenic affects the expression of SLC6A6 mRNA CTD PMID:18414638 arsenic atom multiple interactions ISO RGD:69004 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:69004 6480464 Arsenic affects the methylation of SLC6A6 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC6A6 gene CTD PMID:28931070 avobenzone increases expression ISO RGD:69004 6480464 avobenzone results in increased expression of SLC6A6 mRNA CTD PMID:31016361 azathioprine increases expression ISO RGD:69004 6480464 Azathioprine results in increased expression of SLC6A6 mRNA CTD PMID:22623647 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of SLC6A6 mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:62205 6480464 Benzo(a)pyrene results in decreased expression of SLC6A6 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:69004 6480464 Benzo(a)pyrene affects the methylation of SLC6A6 3' UTR, Benzo(a)pyrene affects the methylation of SLC6A6 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:69004 6480464 Benzo(a)pyrene results in increased methylation of SLC6A6 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:69004 6480464 Benzo(a)pyrene results in increased expression of SLC6A6 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69004 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I increases expression ISO RGD:69004 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC6A6 mRNA CTD PMID:18164116 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of SLC6A6 mRNA CTD PMID:16648578 bisphenol A increases expression ISO RGD:69004 6480464 bisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:23019147 , PMID:29275510 bisphenol A multiple interactions ISO RGD:69004 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:69004 6480464 bisphenol A results in decreased methylation of SLC6A6 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:69004 6480464 bisphenol A results in decreased expression of SLC6A6 protein CTD PMID:33376534 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:30816183 more ... bisphenol F multiple interactions ISO RGD:69004 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC6A6 mRNA CTD PMID:32479839 butanal increases expression ISO RGD:69004 6480464 butyraldehyde results in increased expression of SLC6A6 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:69004 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC6A6 mRNA CTD PMID:29741670 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC6A6 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:69004 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC6A6 mRNA CTD PMID:29741670 cadmium dichloride increases expression ISO RGD:69004 6480464 Cadmium Chloride results in increased expression of SLC6A6 mRNA CTD PMID:25596134 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC6A6 mRNA CTD PMID:25993096 cadmium sulfate multiple interactions ISO RGD:69004 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 carbon nanotube decreases expression ISO RGD:62205 6480464 Nanotubes, Carbon results in decreased expression of SLC6A6 mRNA CTD PMID:25554681 , PMID:25620056 chlordecone increases expression ISO RGD:62205 6480464 Chlordecone results in increased expression of SLC6A6 mRNA CTD PMID:33711761 chloroacetaldehyde affects expression ISO RGD:69004 6480464 chloroacetaldehyde affects the expression of SLC6A6 mRNA CTD PMID:25596134 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of SLC6A6 mRNA CTD PMID:23125180 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of SLC6A6 mRNA CTD PMID:25596134 cidofovir anhydrous affects expression ISO RGD:69004 6480464 Cidofovir affects the expression of SLC6A6 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:69004 6480464 Cisplatin results in decreased expression of SLC6A6 mRNA CTD PMID:27594783 cisplatin decreases response to substance ISO RGD:62205 6480464 SLC6A6 protein results in decreased susceptibility to Cisplatin CTD PMID:21220912 cisplatin increases expression ISO RGD:69004 6480464 Cisplatin results in increased expression of SLC6A6 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:69004 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC6A6 mRNA CTD PMID:27392435 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of SLC6A6 mRNA CTD PMID:19483382 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 cobalt dichloride multiple interactions ISO RGD:69004 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 copper(II) sulfate increases expression ISO RGD:69004 6480464 Copper Sulfate results in increased expression of SLC6A6 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:69004 6480464 Asbestos, Crocidolite results in increased expression of SLC6A6 mRNA CTD PMID:25351596 cyclosporin A decreases expression ISO RGD:69004 6480464 Cyclosporine results in decreased expression of SLC6A6 mRNA CTD PMID:25596134 cyclosporin A increases expression ISO RGD:69004 6480464 Cyclosporine results in increased expression of SLC6A6 mRNA CTD PMID:20106945 , PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SLC6A6 mRNA CTD PMID:23640034 dextran sulfate multiple interactions ISO RGD:62205 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A6 mRNA CTD PMID:29950665 dibutyl phthalate increases expression ISO RGD:62205 6480464 Dibutyl Phthalate results in increased expression of SLC6A6 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC6A6 mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO RGD:69004 6480464 Diethylstilbestrol results in increased expression of SLC6A6 mRNA CTD PMID:19371625 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of SLC6A6 mRNA CTD PMID:17720352 dioxygen increases expression ISO RGD:69004 6480464 Oxygen deficiency results in increased expression of SLC6A6 mRNA CTD PMID:25596134 , PMID:26516004 dorsomorphin multiple interactions ISO RGD:69004 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SLC6A6 mRNA CTD PMID:17105721 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC6A6 mRNA CTD PMID:29391264 fenthion increases expression ISO RGD:62205 6480464 Fenthion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 fulvestrant increases methylation ISO RGD:69004 6480464 Fulvestrant results in increased methylation of SLC6A6 gene CTD PMID:31601247 fulvestrant multiple interactions ISO RGD:69004 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 genistein increases expression ISO RGD:69004 6480464 Genistein results in increased expression of SLC6A6 mRNA CTD PMID:19371625 , PMID:23019147 genistein affects expression ISO RGD:69004 6480464 Genistein affects the expression of SLC6A6 mRNA CTD PMID:26865667 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC6A6 mRNA CTD PMID:33387578 imipramine affects expression EXP 6480464 Imipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC6A6 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:22129741 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of SLC6A6 mRNA CTD PMID:18355885 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of SLC6A6 mRNA CTD PMID:19483382 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of SLC6A6 mRNA CTD PMID:11578147 lead(II) chloride multiple interactions ISO RGD:69004 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 manganese atom increases expression EXP 6480464 Manganese results in increased expression of SLC6A6 mRNA CTD PMID:20832424 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of SLC6A6 mRNA CTD PMID:20832424 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC6A6 mRNA CTD PMID:25596134 methidathion increases expression ISO RGD:62205 6480464 methidathion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:22129741 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A6 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC6A6 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:18164116 , PMID:22129741 N-Nitrosopyrrolidine increases expression ISO RGD:69004 6480464 N-Nitrosopyrrolidine results in increased expression of SLC6A6 mRNA CTD PMID:32234424 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC6A6 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:69004 6480464 Nickel results in increased expression of SLC6A6 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:69004 6480464 nickel sulfate results in increased expression of SLC6A6 mRNA CTD PMID:22714537 O-methyleugenol increases expression ISO RGD:69004 6480464 methyleugenol results in increased expression of SLC6A6 mRNA CTD PMID:32234424 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of SLC6A6 mRNA CTD PMID:19483382 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC6A6 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:69004 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA more ... CTD PMID:32699268 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of SLC6A6 mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:62205 6480464 Acetaminophen affects the expression of SLC6A6 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:69004 6480464 Acetaminophen results in increased expression of SLC6A6 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC6A6 mRNA CTD PMID:17202762 more ... parathion increases expression ISO RGD:62205 6480464 Parathion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO RGD:62205 6480464 Pentachlorophenol results in increased expression of SLC6A6 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62205 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC6A6 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69004 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC6A6 mRNA CTD PMID:32790152 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:69004 6480464 perfluorooctanoic acid results in decreased expression of SLC6A6 mRNA CTD PMID:36326898 phenformin increases expression EXP 6480464 Phenformin results in increased expression of SLC6A6 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:62205 6480464 Phenobarbital affects the expression of SLC6A6 mRNA CTD PMID:23091169 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of SLC6A6 mRNA CTD PMID:19483382 pirinixic acid decreases expression ISO RGD:62205 6480464 pirinixic acid results in decreased expression of SLC6A6 mRNA CTD PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 potassium chromate decreases expression ISO RGD:69004 6480464 potassium chromate(VI) results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:69004 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:62205 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A6 mRNA CTD PMID:28903501 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SLC6A6 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC6A6 mRNA CTD PMID:19013527 SB 431542 multiple interactions ISO RGD:69004 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:69004 6480464 Asbestos, Serpentine results in decreased expression of SLC6A6 mRNA CTD PMID:21148743 silicon dioxide increases expression ISO RGD:69004 6480464 Silicon Dioxide analog results in increased expression of SLC6A6 mRNA, Silicon Dioxide results in increased expression of SLC6A6 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenate increases expression ISO RGD:62205 6480464 sodium arsenate results in increased expression of SLC6A6 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:69004 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:69004 6480464 sodium arsenite results in increased expression of SLC6A6 mRNA CTD PMID:21281968 more ... sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLC6A6 mRNA CTD PMID:25993096 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SLC6A6 mRNA CTD PMID:25905778 sulforaphane increases expression ISO RGD:69004 6480464 sulforaphane results in increased expression of SLC6A6 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:69004 6480464 Sunitinib results in decreased expression of SLC6A6 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:62205 6480464 Tamoxifen affects the expression of SLC6A6 mRNA CTD PMID:17555576 taurine increases expression ISO RGD:62205 6480464 Taurine results in increased expression of SLC6A6 protein CTD PMID:32017914 temozolomide decreases expression ISO RGD:69004 6480464 Temozolomide results in decreased expression of SLC6A6 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC6A6 protein CTD PMID:17544377 tetrachloromethane decreases expression ISO RGD:62205 6480464 Carbon Tetrachloride results in decreased expression of SLC6A6 mRNA CTD PMID:31919559 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of SLC6A6 mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC6A6 mRNA CTD PMID:34492290 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC6A6 mRNA CTD PMID:23411599 titanium dioxide multiple interactions ISO RGD:62205 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A6 mRNA CTD PMID:29950665 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of SLC6A6 mRNA CTD PMID:16979414 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC6A6 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC6A6 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:69004 6480464 trichostatin A results in increased expression of SLC6A6 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:69004 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLC6A6 mRNA CTD PMID:30589522 triptonide affects expression ISO RGD:62205 6480464 triptonide affects the expression of SLC6A6 mRNA CTD PMID:33045310 valproic acid increases methylation ISO RGD:69004 6480464 Valproic Acid results in increased methylation of SLC6A6 gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SLC6A6 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:69004 6480464 Valproic Acid results in increased expression of SLC6A6 mRNA CTD PMID:24383497 , PMID:24935251 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of SLC6A6 mRNA CTD PMID:25423262 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC6A6 mRNA CTD PMID:23034163 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC6A6 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:69004 6480464 vorinostat results in decreased expression of SLC6A6 mRNA CTD PMID:27188386 zearalenone increases expression ISO RGD:69004 6480464 Zearalenone results in increased expression of SLC6A6 mRNA CTD PMID:19371625